Hema Tallman: Imagine Needing A Treatment So Rare, So Specific, That Only Plasma-derived Medicine Can Help
Hema Tallman, SVP- Global Head of BioLife Plasma Services at Takeda, reposted from Takeda on LinkedIn:
”Imagine needing a treatment so rare, so specific, that only plasma-derived medicine can help.
For hundreds of thousands of people around the world, this is their reality – and their hope.
At BioLife Plasma Services, our employees are the heartbeat of this hope.
We welcome donors with care, ensure safety at every step, and help transform each donation into life-sustaining medicine.
I’m inspired by the work of Thomas – and all our employees – every day.”
Takeda shared on LinkedIn:
”Plasma is required to produce life-sustaining medicine for people with rare and serious health conditions and can’t be manufactured. It’s a precious gift that comes from generous donors. But how does this life-sustaining resource get from donor to patient?
It takes dedication, care and a whole lot of heart. Our colleagues at BioLife Plasma Services are the vital starting point in this journey – ensuring a safe and welcoming experience for every donor, and collecting the plasma that transforms lives.
This International Plasma Awareness Week (IPAW), get an inside look at the inspiring work to help maintain a reliable supply of plasma for patients.”
Read more here.
Stay updated with Hemostasis Today.
-
Jan 11, 2026, 06:18Filippo Cademartiri on Why Vascular Health Is Cognitive Health
-
Jan 11, 2026, 06:01Maira Dastgir N on Cannabis-Induced Ischemic Stroke
-
Jan 11, 2026, 05:51Nishant K Mishra on Preventing Post-Stroke Seizures
-
Jan 11, 2026, 05:41Indunil Karunarathna on CSF Xanthochromia in SAH
-
Jan 11, 2026, 05:22Mitchell Elkind on The New York Times Brain Health Challenge: Food Is Brain Medicine!
-
Jan 11, 2026, 03:55Building Better Care for Bleeding Disorders in Zambia․ Chatowa’s Journey
-
Jan 11, 2026, 03:54Unsupervised Machine Learning for Patient Stratification in Cardiovascular Disease
-
Jan 11, 2026, 03:54DAPT De-escalation After PCI․ Where Do We Stand Today?
-
Jan 11, 2026, 03:53Mostafa Faisal Mohammed: Avatrombopag in Aplastic Anemia